As pharmaceutical manufacturing processes continue to become more streamlined and therapy delivery continues to evolve, so has endotoxin control. Five topics in particular have dominated recent discussions around endotoxin control: low endotoxin recovery, non-LAL detection methods, modulating impurities, data integrity and depyrogenation.